Glycopyrrolate Injection
Product Images NDC 51662-1484

4 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 51662-1484). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clinical (Clinical Pharma)

Clinical (Clinical Pharma)
A data table comparing pharmacokinetic parameters for two groups receiving glycopyrrolate: 6 µg/kg intravenous (IV) and 8 µg/kg intramuscular (IM). Parameters listed include half-life (t1/2), volume of distribution (Vss), clearance (CL), time to maximum concentration (Tmax), maximum concentration (Cmax), and area under the curve (AUC), with respective values and standard deviations shown.*
FDA Label Image

Serialized Labeling (Serialized Vial Labeling)

Serialized Labeling (Serialized Vial Labeling)
A vial of Glycopyrrolate Injection, USP, 0.2 mg/mL (4 mg/20 mL) in a clear glass container with a teal flip-off cap. The label indicates it is a 20 mL multiple dose vial for intramuscular or intravenous administration. It includes warnings such as 'NOT FOR USE IN NEWBORNS' and notes the presence of benzyl alcohol as a preservative. The labeler is HF Acquisition Co LLC, DBA HealthFirst, and there is a barcode and NDC number 0143-9679-01 visible.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of glycopyrrolate shown as a molecular diagram with labeled functional groups. The formula C19H28BrNO3 and molecular weight 398.33 are indicated below the structure.*
FDA Label Image

Vial Label (Vial Labeling)

Vial Label (Vial Labeling)
Label for Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) in a 20 mL multiple dose vial. The label indicates it contains benzyl alcohol for intramuscular or intravenous administration and is distributed by West-Ward, Eatontown, NJ. Instructions note usual dosage is on the package insert and storage is at controlled room temperature 20° to 25°C (68° to 77°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.